Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Similar Items

• Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
  od: Taher AT, i dr.
  Izdano: (2016-12-01)
• Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox
  od: Taher, Ali T, i dr.
  Izdano: (2014)
• Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia
  od: Trachtenberg, Felicia, i dr.
  Izdano: (2011)
• Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
  od: Kontoghiorghe, Christina N, i dr.
  Izdano: (2016)
• Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
  od: Ansari, Shahla, i dr.
  Izdano: (2017)